BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8564781)

  • 1. Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse.
    Agbenyega ET; Morton RH; Hatton PA; Wareham AC
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jul; 111(3):397-403. PubMed ID: 8564781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
    Hayes A; Williams DA
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.
    Morton RH; Agbenyega ET; Hatton PA; Wareham AC
    Pflugers Arch; 1995 Dec; 431(2):237-43. PubMed ID: 9026784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
    Lynch GS; Hayes A; Campbell SP; Williams DA
    J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of the beta-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats].
    Rehfeldt C; Weikard R; Reichel K
    Arch Tierernahr; 1994; 45(4):333-44. PubMed ID: 7487480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
    Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
    Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.
    Sundal S; Katoch SS; Sharma S
    Indian J Biochem Biophys; 2006 Jun; 43(3):160-6. PubMed ID: 16967905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
    Mounier R; CavaliƩ H; Lac G; Clottes E
    Pflugers Arch; 2007 Jan; 453(4):497-507. PubMed ID: 17093970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat.
    Stevens L; Firinga C; Gohlsch B; Bastide B; Mounier Y; Pette D
    Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1558-63. PubMed ID: 11029303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of transgenic mice to beta-adrenergic agonist administration is different from that of normal mice.
    Sharma AK; Lee YB; Murray JD
    J Anim Sci; 1997 Aug; 75(8):2092-9. PubMed ID: 9263056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clenbuterol on growth, carcase and skeletal muscle characteristics in broiler chickens.
    Rehfeldt C; Schadereit R; Weikard R; Reichel K
    Br Poult Sci; 1997 Sep; 38(4):366-73. PubMed ID: 9347144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of denervated muscle form and function by clenbuterol in a rat model of peripheral nerve injury.
    Fitton AR; Berry MS; McGregor AD
    J Hand Surg Br; 2001 Aug; 26(4):335-46. PubMed ID: 11469836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
    Chen KD; Alway SE
    Muscle Nerve; 2001 Feb; 24(2):211-22. PubMed ID: 11180204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
    Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol.
    Gregorevic P; Williams DA; Lynch GS
    Muscle Nerve; 2002 Feb; 25(2):194-201. PubMed ID: 11870686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
    Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
    J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibited longitudinal growth of bones in young male rats by clenbuterol.
    Kitaura T; Tsunekawa N; Kraemer WJ
    Med Sci Sports Exerc; 2002 Feb; 34(2):267-73. PubMed ID: 11828236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat.
    Rajab P; Fox J; Riaz S; Tomlinson D; Ball D; Greenhaff PL
    Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1076-81. PubMed ID: 10956268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat.
    Ricart-Firinga C; Stevens L; Canu MH; Nemirovskaya TL; Mounier Y
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C582-8. PubMed ID: 10712247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.